Go to deals
Private Equity | Other Industries

BaltCap has sold Labochema to French laboratory supply distributor Dominique Dutscher

BaltCap Lithuania SME Fund has sold its 46% shareholding in Labochema UAB, a Lithuanian laboratory supplies trading company, to Dominique Dutscher. Labochema’s CEO and the chairman also sold their shareholdings. As a result of the transaction, Dominique Dutscher now controls 100% of Labochema.

Founded in 1997, Labochema is a provider of integrated laboratory solutions, with branches in all three Baltic countries. It also controls Gidela, a fast-growing laboratory furniture company. The companies employ more than 50 people. The company had US$15.1 million revenues in 2020.

Dutscher is one of the leading European laboratory supply distributors, with annual revenues of US$365 million and 700 employees in nine countries. Since 2020, the company is owned by private equity fund manager LBO France (with US$7.3 billion assets under management) and the management team, led by Dominique Wencker. Based in France, Dutscher has experienced strong organic growth complemented by targeted acquisitions in France, Spain, Italy and the UK.

Oaklins’ team in Lithuania acted as a full-scope M&A advisor to the sellers through all stages of the process.

Service
M&A sell-side
Parties

Talk to the deal team

 Martynas  Visockas

Martynas Visockas

Partner

Vilnius, Lithuania
Oaklins Baltics
 Mindaugas  Matulaitis

Mindaugas Matulaitis

Associate Partner

Vilnius, Lithuania
Oaklins Baltics

Related deals

Matera has acquired a majority stake in Onidata Tecnologia
Private Equity | Financial Services | TMT

Matera has acquired a majority stake in Onidata Tecnologia

Matera has acquired a majority stake in Onidata Tecnologia.

Learn more
Frediani has been acquired by The Florence Group
Private Equity | Consumer & Retail

Frediani has been acquired by The Florence Group

The Frediani family have sold Frediani S.r.l. to The Florence Group.

Learn more
Serenis and three other independent clinics have acquired Clinique du Chateau de Vernhes
Private Equity | Healthcare

Serenis and three other independent clinics have acquired Clinique du Chateau de Vernhes

Groupe Serenis and three other independent clinics have acquired Clinique du Chateau de Vernhes from the funding family.

Learn more